FLORAZOLE ER 750 MG
METRONIDAZOLE : 750 MG · DIN 02244405 · FERRING INC
Health Canada status: CANCELLED POST MARKET
What is FLORAZOLE ER?
FLORAZOLE ER 750 MG contains METRONIDAZOLE : 750 MG. It is listed in the Health Canada Drug Product Database under DIN 02244405, held by FERRING INC, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Sep-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is FLORAZOLE ER called?
The same molecule, METRONIDAZOLE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Flagyl | Latin | Australia, Bahrain, Morocco, South Africa |
| METRONIDAMED | Latin | Australia |
| METRONIDAZOLE NORIDEM | Latin | Czechia |
| METROZAL | Latin | Morocco |
| RIAZOLE | Latin | Bahrain, Saudi Arabia |
| Suprazole | Latin | Bahrain, Saudi Arabia, South Africa |
| Anaerobex Filmtabl. | Latin | Austria |
| METRONIDAZOLE | Latin | Bahrain, Lebanon |
| NIDAZOL | Latin | Morocco |
| Trichazole | Latin | South Africa |
| ANAZOL | Latin | Saudi Arabia |
| Bemetrazole | Latin | South Africa |
| Flagyl S | Latin | Australia |
| Metagyl Forte Tablets | Latin | South Africa |
| Metrobactin vet | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02244405 |
|---|---|
| Brand name | FLORAZOLE ER |
| Generic / active ingredient | METRONIDAZOLE : 750 MG |
| Manufacturer | FERRING INC |
| Strength | 750 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01XD01 METRONIDAZOLE |
| AHFS class | 08:30.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Sep-2012 |
| Original market date | 2002-10-10 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02244405 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2244405 |
| Brand name | FLORAZOLE ER |
| Active ingredient / INN | METRONIDAZOLE : 750 MG |
| ATC code | J01XD01 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01 |
| AHFS class | 08:30.92 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | FERRING INC |
Which pack is which?
| Strength on the label | 750 MG |
|---|---|
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is METRONIDAZOLE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Discontinued — reported by PFIZER CANADA ULC, last seen 19 May 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code J01XD01 METRONIDAZOLE. 2 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| METRONIDAZOLE INJECTION, USP | 5 MG | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 00870420 |
| PMS-METRONIDAZOLE | 500 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 00783137 |
| METRONIDAZOLE INJECTION USP | Strength | Solution | PFIZER CANADA ULC 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5 | CANCELLED POST MARKET | DIN 00649074 |
| METRONIDAZOLE TAB 250MG | 250 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00420409 |
| NOVO-NIDAZOL TAB 250MG | 250 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00021555 |
| PMS-METRONIDAZOLE 250MG/TAB | 250 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 00584339 |
Who else supplies METRONIDAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METRONIDAZOLE appears in 2910 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does METRONIDAZOLE cost around the world?
METRONIDAZOLE is listed on 14 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 5 | 62 | USD███.██ |
| Saudi Arabia | public | 46 | 52 | SAR███.██ |
| South Africa | single exit price | 41 | 50 | ZAR███.██ |
| Morocco | PPV (public price) | 14 | 26 | MAD███.██ |
| United Arab Emirates | public | 13 | 18 | AED███.██ |
| Greece | producer price (ex-factory) | 16 | 16 | EUR███.██ |
| Australia | ex-manufacturer | 5 | 14 | AUD███.██ |
| Bahrain | retail (max) | 12 | 13 | BHD███.██ |
| Czechia | max producer price (ex-factory) | 5 | 9 | CZK███.██ |
| United Kingdom | hospital | 7 | 7 | GBP███.██ |
| Austria | KVP (Kassenverkaufspreis) | 1 | 3 | EUR███.██ |
| Lebanon | public price (USD, Decision 119/1) | 2 | 3 | USD███.██ |
| Iceland | max wholesale | 1 | 2 | ISK███.██ |
| Luxembourg | reimbursement | 1 | 1 | EUR███.██ |
276 pack listings across 169 brand entries and 13 price bases, refreshed 08 Sep 2026. Ranges span every METRONIDAZOLE pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.